Sökning: "Idiopathic inflammatory myopathies"
Visar resultat 6 - 10 av 23 avhandlingar innehållade orden Idiopathic inflammatory myopathies.
6. Studies on autoantibodies and inflammatory markers in patients with idiopathic inflammatory myopathies
Sammanfattning : Idiopathic Inflammatory myopathies (IIM), commonly known as myositis, are chronic autoimmune diseases characterized by low muscle strength and low muscle endurance as main features. However, a high number of patients may develop extra muscular manifestations such as interstitial lung disease, skin rash or arthritis. LÄS MER
7. The Clinical and Pathological Spectrum of Idiopathic Inflammatory Myopathies : Implications for pathogenesis, classification and diagnosis
Sammanfattning : Background: Idiopathic inflammatory myopathies (IIM) constitute a heterogeneous group of diseases with severe consequences for the life of affected patients. Dermatomyositis, polymyositis and inclusion body myositis (IBM) are the classical representatives of this group. LÄS MER
8. The role of autoantibodies in inflammatory myopathies
Sammanfattning : Polymyositis (PM), dermatomyositis (DM) and inclusion body myositis (IBM), collectively called myositis, are chronic inflammatory myopathies. These disease subsets are heterogeneous but share some features, such as skeletal muscle weakness and inflammatory cell infiltrates in muscle tissue. LÄS MER
9. Physical exercise as a targeted therapy in idiopathic inflammatory myopathies
Sammanfattning : Idiopathic inflammatory myopathies are comprised of polymyositis (PM) and dermatomyositis (DM) with muscle impairment being the primary clinical feature. With the currently recommended treatment regimen, a majority of patients develop sustained impaired muscle performance and poor health for undetermined reasons. LÄS MER
10. Idiopathic inflammatory myopathies and cancer : familial risk, genetics and consequences
Sammanfattning : Idiopathic inflammatory myopathies (IIMs) are a group of rare rheumatic inflammatory diseases (RIDs), characterised by a diverse range of clinical, serological and histopathological characteristics, with muscle weakness as a shared hallmark. While advancements in disease management have improved the survival rates of patients with IIM, the mortality rate among patients with IIM is still higher than the general population, mainly due to association with comorbidities such as cancer. LÄS MER